Hexagon Bio Funding & Investors
Hexagon Bio is a data-driven biotech developing targeted small molecule therapeutics. Our proprietary platform combines data science and synthetic biology to discover and engineer drugs from DNA sequences. We are mining fungal genomes for inspiration for the next generation of targeted therapies for diseases with unmet needs.
hexagonbio.comTotal Amount Raised: $193,600,000
Hexagon Bio Funding Rounds
Series B
$77,300,000
Series B Investors
CPPIB Credit Investments8VCNextech InvestColumn GroupTwo Sigma VenturesATEL Capital GroupSeries Unknown
$61,000,001
Series Unknown Investors
Nextech Invest8VCSoftBank Vision FundCasdin CapitalTwo Sigma VenturesColumn GroupSeries A
$47,000,000
Series A Investors
Column Group8VCTwo Sigma VenturesLeFrak OrganizationSeed
$8,300,000
Seed Investors
8VCbpd partners
Funding info provided by Diffbot.